Trethera (Formerly Triangle Therapeutics)
Small molecules that control dna replication and integrity.
Launch date
Employees
Market cap
-
Enterprise valuation
€27—40m (Dealroom.co estimates Feb 2016.)
Beverly Hills California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $7.4m | Early VC | |
* | $1.6m | Grant | |
* | $2.0m | Grant | |
* | $600k | Grant | |
| Total Funding | €10.5m | ||
Recent News about Trethera (Formerly Triangle Therapeutics)
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.